Evidence map›Paper›PMID 41992797›Full record

ArticleHealth expectations : an international journal of public participation in health care and health policy2026

Understanding the Psychological Impacts of Shielding From COVID-19 for Immunocompromised Individuals.

Anna Gray, Julie Barnett, Luca Bernardi, Jo Daniels

Abstract read
In one paragraph

Article in Health expectations : an international journal of public participation in health care and health policy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Anna GrayDepartment of Psychology, University of Bath, Bath, UK.ORCID 0000-0003-0546-6822
Julie BarnettDepartment of Psychology, University of Bath, Bath, UK.ORCID 0000-0001-5740-0863
Luca BernardiDepartment of Politics, University of Liverpool, Liverpool, UK.ORCID 0000-0001-5875-9990
Jo DanielsDepartment of Psychology, University of Bath, Bath, UK.ORCID 0000-0003-3067-9416

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study aimed to explore the impact of shielding amongst immunocompromised individuals following the COVID-19 pandemic.

designThis study used a cross-sectional exploratory qualitative design.

methodsA national survey was launched in July 2023 aiming to collect information on the lived experience of individuals who were still shielding. The final question to this study was 'what has been the worst aspect of shielding for you?'. In total, 457 individuals (57%) responded to this question. Data were analysed using thematic analysis.

resultsThree themes were identified, associated with the impact of shielding: (1) Navigating risk: including fear of infection, distrust in institutional guidance and measures. (2) Loss and longing: including profound isolation, grieving lost time, loss of freedom and relationships. (3) Betrayed and forsaken: a sense of intentional abandonment by government and lack of understanding from loved ones, causing distress and mistrust.

conclusionThe findings from this study indicate that individuals who are shielding continue to experience profound difficulties that require attention. Measures must be introduced to mitigate the impact of COVID in the immunocompromised, including improving public health messaging and strategies to tackle isolation. Given the high likelihood of future pandemics, it is imperative that strategies are developed to address the needs of its most vulnerable populations. PATIENT OR PUBLIC CONTRIBUTION: Patient and public contribution has formed an integral part in the assignment of this study. The rationale and design of this study was created in partnership with Forgotten Lives UK and the National Clinical Expert Group, who represent 125 clinicians, across 4 nations and 17 medical specialities treating immunocompromised patients.

Indexed as

COVID-19Immunocompromised HostAdultAgedCross-Sectional StudiesFearFemaleHumansMaleMiddle AgedQualitative ResearchSARS-CoV-2TrustcoronavirusCOVID‐19immunocompromisedpandemicshielding

Identifiers

PMID41992797
PMCPMC13087511

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.